Data / Form D filings / Esculon, Inc.
Esculon, Inc.: Form D filings
Esculon, Inc., a biotechnology company in Omaha, NE, filed 3 Form D notices with the SEC in 2017. The latest, on November 27, 2017, reports $2.9 million sold of a $2.9 million offering to 14 investors.
Find out what Esculon, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3929 Harney Street, Suite 3008, Omaha, NE, 68198
- Phone
- (402) 417-0740
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2016
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1709643
The full lists. Form D filings in Nebraska: 172 rows, $8.60, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 27, 2017 | Amendment | $2,925,826 | $2,925,826 | $0 | 14 | Jun 7, 2017 | sec.gov |
| Jun 19, 2017 | Amendment | $2,524,664 | $1,554,984 | $969,680 | 14 | Jun 7, 2017 | sec.gov |
| Jun 19, 2017 | New notice | $1,500,000 | $969,680 | $530,320 | 14 | Jun 7, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Danial Burnett | Director | |
| Carter Meyer | Director | |
| Evan Luxon | Director | |
| Deepak Gangahar | Director | |
| Alan Chesler | Director |
Other biotechnology companies in Nebraska that filed recently
- Virtual Incision Corp $35.1 million · Oct 5, 2026
Every Form D from the week of Nov 27, 2017 · All recent filings in Nebraska · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Esculon, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.